undamentalytics Newsletter
Sign in

Celularity Inc balance sheet

At the end of fiscal 2025, Celularity Inc had total assets of $107m, total liabilities of $145m and shareholders' equity of −$38.1m. It held $6.2m in cash against $33.8m of debt: net debt of $27.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents5437140161
Receivables134101455
Inventory101056511
Total current assets7259342021126
Goodwill1231231207777
Total assets43141440114413310796
Accounts payable59614232615
Deferred revenue (current)5223455
Total current liabilities27266267548160
Short-term debt——3839———
Long-term debt—————34—
Total debt00385603434
Total liabilities412315202103124145132
Shareholders' equity−53199199419−38−36
Non-controlling interests and other (assets − liabilities − equity)550——————
Net debt (negative = net cash)−54−372456−12833
Shares outstanding——15m19m23m29m29m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CELU vs CTMXCELU vs SCYXCELU vs PRQR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Celularity Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Celularity Inc.